Shane Krummen Atwell

Person

Carlsbad, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
IgG bispecific antibodies and processes for preparation
- Patent number 11,976,136
- Issue date May 7, 2024
- Eli Lilly and Company
- Hector Aldaz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human interleukin-4 receptor alpha antibodies
- Patent number 11,891,441
- Issue date Feb 6, 2024
- Eli Lilly and Company
- Shane Krummen Atwell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
BTLA agonist antibodies and uses thereof
- Patent number 11,396,545
- Issue date Jul 26, 2022
- Eli Lilly and Company
- Shane Krummen Atwell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IgG bispecific antibodies and processes for preparation
- Patent number 10,774,156
- Issue date Sep 15, 2020
- Eli Lilly and Company
- Hector Aldaz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
BTLA agonist antibodies and uses thereof
- Patent number 10,604,573
- Issue date Mar 31, 2020
- Eli Lilly and Company
- Shane Krummen Atwell
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HUMAN INTERLEUKIN-4 RECEPTOR ALPHA ANTIBODY GLUCOCORTICOID CONJUGATES
- Publication number 20240100176
- Publication date Mar 28, 2024
- Eli Lilly and Company
- Shane Krummen Atwell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Crystallization of Antibodies or Antigen-Binding Fragments
- Publication number 20230137966
- Publication date May 4, 2023
- Eli Lilly and Company
- Shane Krummen Atwell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMAN INTERLEUKIN-4 RECEPTOR ALPHA ANTIBODIES
- Publication number 20230064378
- Publication date Mar 2, 2023
- Eli Lilly and Company
- Shane Krummen ATWELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IgG Bispecific Antibodies and Processes for Preparation
- Publication number 20210054103
- Publication date Feb 25, 2021
- Eli Lilly and Company
- Hector Aldaz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BTLA AGONIST ANTIBODIES AND USES THEREOF
- Publication number 20200239578
- Publication date Jul 30, 2020
- Eli Lilly and Company
- Shane Krummen Atwell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BTLA AGONIST ANTIBODIES AND USES THEREOF
- Publication number 20180334502
- Publication date Nov 22, 2018
- Eli Lilly and Company
- Shane Krummen Atwell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IgG Bispecific Antibodies and Processes for Preparation
- Publication number 20180009908
- Publication date Jan 11, 2018
- Eli Lilly and Company
- Hector Aldaz
- C07 - ORGANIC CHEMISTRY

Shane Krummen Atwell

Person

Patents Grantslast 30 patents

IgG bispecific antibodies and processes for preparation

Human interleukin-4 receptor alpha antibodies

BTLA agonist antibodies and uses thereof

IgG bispecific antibodies and processes for preparation

BTLA agonist antibodies and uses thereof

Patents Applicationslast 30 patents

HUMAN INTERLEUKIN-4 RECEPTOR ALPHA ANTIBODY GLUCOCORTICOID CONJUGATES

Crystallization of Antibodies or Antigen-Binding Fragments

HUMAN INTERLEUKIN-4 RECEPTOR ALPHA ANTIBODIES

IgG Bispecific Antibodies and Processes for Preparation

BTLA AGONIST ANTIBODIES AND USES THEREOF

BTLA AGONIST ANTIBODIES AND USES THEREOF

IgG Bispecific Antibodies and Processes for Preparation